Live feed
·
INSIDERFiling
Halozyme Therapeutics Inc. logo

SVP, CHIEF FINANCIAL OFFICER Labrosse Nicole converted options into 23,773 shares and covered exercise/tax liability with 12,894 shares, increasing direct ownership by 49% to 32,958 units (SEC Form 4)